Concepedia

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Mark Löwenberg, Séverine Vermeire, Nahid Mostafavi, Frank Hoentjen, Denis Franchimont, Peter Bossuyt, Pieter Hindryckx, Theo Rispens, Annick de Vries, C. Janneke van der Woude,

Gastroenterology · 2019 · 128 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

Marco Daperno, Geert D’Haens, Gert Van Assche et al. · Gastrointestinal Endoscopy · 2004 · 1.8K citations

, , +7

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

Karel Geboes · Gut · 2000 · 938 citations · Full text

, , +16

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts et al. · Gastroenterology · 2014 · 705 citations · Full text

, , +15